Drug intelligence / Profile preview

benzocaine

Development stage
Phase 4
Lead developer
Sanofi
Modality
Small Molecules
Administration
Topical, Rectal, Oromucosal, Vaginal
01

Overview

Benzocaine is a local anesthetic of the amino ester class used primarily as a topical agent for the temporary relief of pain and itching associated with minor burns (including sunburn), insect bites or stings, poison ivy/oak/sumac exposure, minor cuts or scratches. It is also used to numb mucous membranes during certain medical procedures. Benzocaine works by diffusing into nerve cells and binding to voltage-gated sodium channels on neuronal membranes. This action prevents sodium influx required for depolarization and propagation of nerve impulses—thereby blocking sensation in the area where it is applied[1][2][5]. Its onset is rapid but duration short (about 10 minutes). Benzocaine does not cause unconsciousness like general anesthetics[2]. It has been widely available over-the-counter in various forms such as gels/jellies/creams/ointments/liquids/sprays[2][4]. The drug carries a risk of methemoglobinemia—a rare but serious blood disorder—and should not be used in children under 2 years old due to this risk[1][4].

Brand names
AnacaineChiggerexMandelayMediconeOutgroSolarcaineBaby Orajel Nighttime FormulaDermoplast Maximum StrengthTopicaineAmericaineAmericaine HemorrhoidalAnbesol LiquidAnbesol Maximum Strength
Other names
ethyl aminobenzoate
02

Targets

SCN10A (Sodium channel protein type X alpha subunit)

Beyond the preview

Go deeper on benzocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on benzocaine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call